Cargando…

The Cost and Impact of Scaling Up Pre-exposure Prophylaxis for HIV Prevention: A Systematic Review of Cost-Effectiveness Modelling Studies

BACKGROUND: Cost-effectiveness studies inform resource allocation, strategy, and policy development. However, due to their complexity, dependence on assumptions made, and inherent uncertainty, synthesising, and generalising the results can be difficult. We assess cost-effectiveness models evaluating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomez, Gabriela B., Borquez, Annick, Case, Kelsey K., Wheelock, Ana, Vassall, Anna, Hankins, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595225/ https://www.ncbi.nlm.nih.gov/pubmed/23554579 http://dx.doi.org/10.1371/journal.pmed.1001401

Ejemplares similares

The impact, cost and cost‐effectiveness of oral pre‐exposure prophylaxis in sub‐Saharan Africa: a scoping review of modelling contributions and way forward
por: Case, Kelsey K, et al.
Publicado: (2019)

Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis
por: Milali, Masabho P., et al.
Publicado: (2023)

Impact and cost‐effectiveness of the national scale‐up of HIV pre‐exposure prophylaxis among female sex workers in South Africa: a modelling analysis
por: Stone, Jack, et al.
Publicado: (2023)

The Potential Impact of Pre-Exposure Prophylaxis for HIV Prevention among Men Who Have Sex with Men and Transwomen in Lima, Peru: A Mathematical Modelling Study
por: Gomez, Gabriela B., et al.
Publicado: (2012)

Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
por: Kim, Susan C, et al.
Publicado: (2010)

Optimal costs of HIV pre-exposure prophylaxis for men who have sex with men
por: McKenney, Jennie, et al.
Publicado: (2017)

The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States
por: Adamson, Blythe J. S., et al.
Publicado: (2017)

The role of costing in the introduction and scale‐up of HIV pre‐exposure prophylaxis: evidence from integrating PrEP into routine maternal and child health and family planning clinics in western Kenya
por: Roberts, D Allen, et al.
Publicado: (2019)

Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa
por: Alistar, Sabina S, et al.
Publicado: (2014)

Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention
por: Reidy, Meghan, et al.
Publicado: (2019)

Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets
por: Kripke, Katharine, et al.
Publicado: (2016)

Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study
por: Wheelock, Ana, et al.
Publicado: (2012)

Correction: Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets
por: Kripke, Katharine, et al.
Publicado: (2016)

The Costs of Scaling Up HIV Prevention for High Risk Groups: Lessons Learned from the Avahan Programme in India
por: Chandrashekar, Sudhashree, et al.
Publicado: (2014)

Voluntary Medical Male Circumcision: An Introduction to the Cost, Impact, and Challenges of Accelerated Scaling Up
por: Hankins, Catherine, et al.
Publicado: (2011)

Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa
por: Price, Joan T., et al.
Publicado: (2016)

Correction: Optimal costs of HIV pre-exposure prophylaxis for men who have sex with men
por: McKenney, Jennie, et al.
Publicado: (2017)

The Costs of Creatinine Testing in the Context of a HIV Pre-Exposure Prophylaxis Demonstration Project in Eswatini
por: Kohler, Stefan, et al.
Publicado: (2021)

Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058
por: van de Vijver, David A M C, et al.
Publicado: (2019)

Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2022)

Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection: progress and emerging issues in research and policy
por: Cáceres, Carlos F, et al.
Publicado: (2016)

Pre-exposure prophylaxis for prevention of HIV infection
por: Lee, Joseph Wei En, et al.
Publicado: (2023)

Pre-exposure prophylaxis of HIV
por: Naswa, Smriti, et al.
Publicado: (2011)

Pre-exposure prophylaxis in HIV
por: Khambhati, Ravi, et al.
Publicado: (2009)

HIV: Pre-exposure Prophylaxis
por: Singh, Ajai Kumar, et al.
Publicado: (2012)

Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) in Preventing HIV-1 Infections in Rural Zambia: A Modeling Study
por: Nichols, Brooke E., et al.
Publicado: (2013)

Evaluating the cost-effectiveness of a pre-exposure prophylaxis program for HIV prevention for men who have sex with men in Japan
por: Yamamoto, Nao, et al.
Publicado: (2022)

Cost utility analysis of HIV pre exposure prophylaxis among men who have sex with men in Israel
por: Ginsberg, G. M., et al.
Publicado: (2020)

Cost-effectiveness analysis of the daily HIV pre-exposure prophylaxis in men who have sex with men in Barcelona
por: López Seguí, Francesc, et al.
Publicado: (2023)

What Determines HIV Prevention Costs at Scale? Evidence from the Avahan Programme in India
por: Lépine, Aurélia, et al.
Publicado: (2016)

Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
por: Tetteh, Raymond A., et al.
Publicado: (2017)

HIV pre-exposure prophylaxis for women
por: Sheth, Anandi N, et al.
Publicado: (2016)

Modeling HIV Pre-Exposure Prophylaxis
por: Straubinger, Thomas, et al.
Publicado: (2020)

Prescribing pre-exposure prophylaxis for HIV
por: Bloch, Mark
Publicado: (2020)

Effectiveness and Cost Effectiveness of Oral Pre-Exposure Prophylaxis in a Portfolio of Prevention Programs for Injection Drug Users in Mixed HIV Epidemics
por: Alistar, Sabina S., et al.
Publicado: (2014)

Pre-exposure prophylaxis in France: How many MSM are eligible and how much will it cost?
por: Ousseine, Youssoufa M., et al.
Publicado: (2022)

Evaluating the Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) and Its Impact on HIV-1 Transmission in South Africa
por: Pretorius, Carel, et al.
Publicado: (2010)

Estimating the Cost-Effectiveness of Pre-Exposure Prophylaxis to Reduce HIV-1 and HSV-2 Incidence in HIV-Serodiscordant Couples in South Africa
por: Jewell, Britta L., et al.
Publicado: (2015)

Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting
por: Montgomery, Madeline C., et al.
Publicado: (2016)

Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention
por: Patel, Rupa R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o4ej7btqi80dti2vicg8r85e64